Gossamer Bio Inc (GOSS) concluded trading on Thursday at a closing price of $0.91, with 16.99 million shares of worth about $15.46 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 76.12% during that period and on December 12, 2024 the price saw a gain of about 27.70%. Currently the company’s common shares owned by public are about 226.60M shares, out of which, 174.03M shares are available for trading.
Stock saw a price change of 27.22% in past 5 days and over the past one month there was a price change of 7.34%. Year-to-date (YTD), GOSS shares are showing a performance of -0.27% which decreased to -11.65% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.50 but also hit the highest price of $1.60 during that period. The average intraday trading volume for Gossamer Bio Inc shares is 1.02 million. The stock is currently trading 25.28% above its 20-day simple moving average (SMA20), while that difference is up 7.31% for SMA50 and it goes to 0.07% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Gossamer Bio Inc (NASDAQ: GOSS) currently have 226.60M outstanding shares and institutions hold larger chunk of about 57.01% of that.
The stock has a current market capitalization of $206.21M and its 3Y-monthly beta is at 1.89. It has posted earnings per share of -$0.33 in the same period. It has Quick Ratio of 6.74 while making debt-to-equity ratio of 3.76. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GOSS, volatility over the week remained 14.17% while standing at 8.41% over the month.
Stock’s fiscal year EPS is expected to rise by 76.06% while it is estimated to decrease by -151.33% in next year. EPS is likely to shrink at an annualized rate of 5.20% for next 5-years, compared to annual growth of 11.99% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Oppenheimer on June 25, 2024 offering an Outperform rating for the stock and assigned a target price of $9 to it. Coverage by Wedbush stated Gossamer Bio Inc (GOSS) stock as an Outperform in their note to investors on April 05, 2024, suggesting a price target of $4 for the stock. Stock get a Neutral rating from Guggenheim on March 01, 2023.
